1h Free Analyst Time
The bio-pharma market is forecasted to grow by USD 204.09 bn during 2023-2028, accelerating at a CAGR of 7.98% during the forecast period. The report on the bio-pharma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of health disorders, the growing geriatric population, and the targeted therapeutic mechanism of biologics.
The bio-pharma market is segmented as below:
By Product
- Monoclonal antibodies
- Recombinant growth factors
- Vaccines
- Recombinant hormones
- Others
By Application
- Oncology
- Autoimmune disorder
- Metabolic disorder
- Hormonal disorder
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the bio-pharma market covers the following areas:
- Bio-pharma market sizing
- Bio-pharma market forecast
- Bio-pharma market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global bio-pharma market: AbbVie Inc., Amgen Inc., Angelini S.p.a., AspenBio, Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Johnson and Johnson, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Vertex Pharmaceuticals Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the rise in production of vaccines.'
According to the report, one of the major drivers for this market is the increasing prevalence of health disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Angelini S.p.a.
- AspenBio
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bayer AG
- Biogen Inc.
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Ipsen Pharma
- Johnson and Johnson
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Vertex Pharmaceuticals Inc.
